Deoxyribonucleic acid (DNA) phosphodiester backbone (DNA)

The DNA phosphodiester backbone is the structural framework of the genetic material, composed of alternating deoxyribose sugar units and phosphate groups linked by covalent phosphodiester bonds [1.1.3]. In proliferating cells, the integrity of this backbone is essential for the processes of DNA replication and transcription, where enzymes like topoisomerases and ligases constantly manipulate these bonds to manage torsional strain and join fragments [1.2.1, 1.3.2]. This structural dependency makes the backbone a critical therapeutic target, particularly in oncology, where drugs are designed to disrupt its continuity [1.1.5]. Agents such as bleomycin and enediynes cause direct oxidative cleavage of the backbone, while topoisomerase inhibitors (e.g., etoposide, irinotecan) stabilize transient nicks, leading to lethal double-strand breaks during replication [1.2.1, 1.2.5]. Other agents like alkylating drugs and platinum compounds form adducts that distort the backbone, interfering with its function as a template [1.2.5]. Because these interventions exploit the high frequency of DNA synthesis in rapidly dividing cells, they provide a degree of selectivity for cancer cells, though they also impact healthy proliferating tissues such as the bone marrow and intestinal epithelium [1.3.2]. Monitoring markers like gamma-H2AX can help assess the extent of backbone damage and therapeutic efficacy [1.3.1].

Other names

DNA backboneSugar-phosphate backboneDNA phosphate backbonePhosphodiester linkage

Inhibition of DNA replication and transcription through direct strand cleavage, stabilization of topoisomerase-DNA covalent complexes (topoisomerase poisoning), and formation of DNA adducts or cross-links that distort the phosphodiester framework.